[NEJM] Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

JavierAngeles Post time 2024-5-9 00:01:24 | Show all posts |Read mode
Reward40points

journal£ºNew England Journal of Medicine

Authors£ºPieter Sonneveld; Meletios A. Dimopoulos; Mario Boccadoro; Hang Quach; P. Joy Ho; Meral Beksac; Cyrille Hulin; Elisabetta Antonioli; Xavier Leleu; Silvia Mangiacavalli; Aurore Perrot; Michele Cavo; Angelo Belotti; Annemiek Broijl; Francesca Gay; Roberto Mina; Inger S. Nijhof; Niels W.C.J. van de Donk; Eirini Katodritou; Fredrik Schjesvold; Anna Sureda Balari; Laura Rosinol; Michel Delforge; Wilfried Roeloffzen; Tobias Silzle; Annette Vangsted; Hermann Einsele; Andrew Spencer; Roman Hajek; Artur Jurczyszyn; Sarah Lonergan; Tahamtan Ahmadi; Yanfang Liu; Jianping Wang; Diego Vieyra; Emilie M.J. van Brummelen; Veronique Vanquickelberghe; Anna Sitthi-Amorn; Carla J. de Boer; Robin Carson; Paula Rodriguez-Otero; Joan Blad¨¦; Philippe Moreau

Published date£º2024-1-25

DOI£º10.1056/nejmoa2312054

PDF link£ºhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2312054

Article link£ºhttp://dx.doi.org/10.1056/nejmoa2312054

Article Source£ºMassachusetts Medical Society¡£


Remark£º

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
tinman Post time 2024-5-9 00:01:25 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Intermediate member
  • post

  • reply

  • points

    300

Latest Reply

Return to the list